Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jan 30 10:08AM ET
10.73
Dollar change
-0.17
Percentage change
-1.61
%
IndexRUT P/E- EPS (ttm)-3.92 Insider Own36.31% Shs Outstand136.71M Perf Week-4.24%
Market Cap1.48B Forward P/E- EPS next Y-3.54 Insider Trans-0.06% Shs Float87.71M Perf Month43.67%
Income-533.34M PEG- EPS next Q-0.87 Inst Own49.37% Short Float8.96% Perf Quarter38.39%
Sales78.62M P/S18.79 EPS this Y15.42% Inst Trans-1.40% Short Ratio3.53 Perf Half Y5.77%
Book/sh9.08 P/B1.18 EPS next Y8.81% ROA-30.10% Short Interest7.86M Perf Year12.66%
Cash/sh7.29 P/C1.47 EPS next 5Y9.14% ROE-36.58% 52W Range6.56 - 14.45 Perf YTD46.12%
Dividend Est.- P/FCF- EPS past 5Y-34.12% ROI-39.98% 52W High-25.78% Beta0.64
Dividend TTM- Quick Ratio8.94 Sales past 5Y532.77% Gross Margin78.24% 52W Low63.49% ATR (14)0.82
Dividend Ex-DateNov 03, 2010 Current Ratio8.94 EPS Y/Y TTM12.57% Oper. Margin-688.05% RSI (14)59.19 Volatility8.19% 8.19%
Employees587 Debt/Eq0.09 Sales Y/Y TTM-33.82% Profit Margin-678.40% Recom1.56 Target Price31.38
Option/ShortYes / Yes LT Debt/Eq0.08 EPS Q/Q-28.52% Payout- Rel Volume0.39 Prev Close10.90
Sales Surprise-57.04% EPS Surprise-48.22% Sales Q/Q-9.81% EarningsOct 31 AMC Avg Volume2.23M Price10.73
SMA207.68% SMA5025.26% SMA20021.73% Trades Volume123,559 Change-1.61%
Date Action Analyst Rating Change Price Target Change
Jan-29-24Downgrade JP Morgan Overweight → Neutral $23 → $9
Sep-08-23Downgrade BofA Securities Buy → Neutral $23 → $14
Mar-06-23Upgrade JP Morgan Neutral → Overweight $35 → $34
Feb-21-23Upgrade Goldman Neutral → Buy $41 → $53
Jan-27-23Upgrade Morgan Stanley Underweight → Equal-Weight $18 → $30
Sep-14-22Initiated SVB Leerink Outperform $40
Sep-09-22Initiated Morgan Stanley Underweight $15
Mar-03-22Upgrade Robert W. Baird Underperform → Neutral $36 → $28
Dec-21-21Downgrade Robert W. Baird Neutral → Underperform $36
Oct-25-21Upgrade JP Morgan Underweight → Neutral $29 → $37
Jan-23-25 06:35PM
Jan-10-25 02:32PM
Jan-09-25 08:30AM
08:18AM
Jan-08-25 04:06PM
07:45AM Loading…
07:45AM
07:25AM
Dec-18-24 09:30AM
Dec-12-24 04:05PM
Dec-03-24 04:07PM
09:02AM
Nov-26-24 09:30AM
Nov-25-24 09:30AM
Nov-18-24 09:15PM
04:05PM
01:39PM Loading…
Nov-15-24 01:39PM
11:00AM
Nov-01-24 05:01PM
12:04AM
Oct-31-24 05:20PM
04:05PM
Oct-18-24 03:04PM
Oct-17-24 04:30PM
Oct-15-24 08:16AM
Oct-03-24 04:00PM
Sep-10-24 08:05AM
Sep-09-24 04:05PM
Sep-04-24 08:30AM
Aug-22-24 08:05AM
Aug-06-24 09:55AM
05:50PM Loading…
Aug-01-24 05:50PM
04:02PM
04:01PM
Jul-18-24 04:05PM
Jul-04-24 10:01AM
Jun-26-24 08:05AM
Jun-06-24 01:26PM
Jun-05-24 02:51PM
05:30AM
May-29-24 04:05PM
08:05AM
May-23-24 04:05PM
May-22-24 08:05AM
May-21-24 08:17AM
May-13-24 07:21PM
May-09-24 10:46AM
May-07-24 09:55AM
May-03-24 01:05PM
06:05AM
04:06AM
May-02-24 09:56PM
06:05PM
04:05PM
Apr-30-24 04:05PM
Apr-24-24 12:00PM
Apr-18-24 08:00AM
Apr-11-24 04:30PM
Apr-04-24 07:01PM
Mar-22-24 07:00AM
Mar-19-24 02:58PM
Mar-13-24 11:07AM
Mar-05-24 08:05AM
Feb-23-24 01:54PM
10:34AM
09:55AM
08:05AM
Feb-22-24 05:50PM
04:05PM
Feb-20-24 04:30PM
Feb-14-24 03:45PM
Feb-01-24 04:05PM
Jan-15-24 11:32AM
Dec-17-23 07:00AM
07:00AM
Dec-13-23 04:05PM
Dec-06-23 04:05PM
Nov-30-23 06:10AM
Nov-13-23 08:00AM
Nov-10-23 08:00AM
Nov-08-23 08:05AM
Nov-04-23 11:42AM
Nov-03-23 09:02AM
Nov-02-23 07:00PM
04:05PM
Oct-30-23 08:00AM
Oct-23-23 02:50AM
Oct-12-23 04:05PM
Oct-11-23 08:00AM
Oct-05-23 04:30PM
Oct-03-23 07:59AM
Sep-20-23 08:00AM
Sep-19-23 05:07AM
Sep-08-23 09:34AM
Aug-29-23 04:30PM
Aug-12-23 11:05AM
Aug-11-23 10:15AM
Aug-07-23 06:03AM
Aug-04-23 01:40PM
Aug-03-23 06:05PM
04:05PM
Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The firm's technology platforms include antibody, T cell, innate immunity and siRNA, which are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. The company was founded by Robert Taylor Nelsen, Klaus Frueh, Jay Parrish, Lawrence Corey, and Louis Picker in April 7, 2016 and is headquartered in San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SATO VICKI LDirectorJan 08 '25Sale12.5210,960137,2191,312,391Jan 08 08:03 PM
VICKI LEE SATODirectorJan 08 '25Proposed Sale7.8943,840345,898Jan 08 04:22 PM
de Verneuil VaninaEVP and General CounselDec 02 '24Sale8.227662556,973Dec 04 03:35 PM
VANINA ALEXANDRA HUARD DE VERNOfficerDec 02 '24Proposed Sale8.2276625Dec 02 05:08 PM
de Verneuil VaninaEVP and General CounselNov 06 '24Sale10.114,39744,45456,973Nov 07 07:20 PM
VANINA DE VERNEUILOfficerNov 06 '24Proposed Sale9.644,39742,387Nov 06 04:55 PM
de Verneuil VaninaEVP and General CounselNov 05 '24Sale9.472,34722,22561,370Nov 05 05:51 PM
de Verneuil VaninaEVP and General CounselNov 01 '24Sale7.201,40310,10763,717Nov 05 05:51 PM
VANINA DE VERNEUILOfficerNov 05 '24Proposed Sale9.372,34721,991Nov 05 04:23 PM
Napolitano JanetDirectorSep 09 '24Sale7.8012,19095,03211,616Sep 10 04:28 PM
JANET ANN NAPOLITANO DirectorSep 09 '24Proposed Sale7.7612,19094,594Sep 09 04:29 PM
Ramasastry SairaDirectorJun 11 '24Sale10.954,00043,78914,619Jun 12 12:21 PM
De Backer MarianneChief Executive OfficerApr 03 '24Sale9.4672,995690,365678,457Apr 04 04:14 PM
HANLY ANN M.EVP & Chief Technology OfficerApr 01 '24Sale10.052,71127,251132,069Apr 02 08:58 PM
Lee SungEVP & Chief Financial OfficerMar 27 '24Sale9.896,00859,404100,492Mar 28 12:18 PM
HANLY ANN M.EVP & Chief Technology OfficerFeb 22 '24Sale10.0512,296123,521134,780Feb 26 07:34 PM
Pang PhillipEVP & Chief Medical OfficerFeb 22 '24Sale10.0514,568146,344250,111Feb 26 07:31 PM
SCANGOS GEORGE ADirectorFeb 26 '24Sale11.6517,722206,522112,989Feb 26 07:30 PM
SCANGOS GEORGE ADirectorFeb 22 '24Sale10.0510,028100,737130,711Feb 26 07:30 PM
SCANGOS GEORGE ADirectorFeb 20 '24Sale10.2216,872172,385140,739Feb 20 09:02 PM
SCANGOS GEORGE ADirectorFeb 16 '24Sale10.2410,878111,386157,611Feb 20 09:02 PM
Pang PhillipEVP & Chief Medical OfficerFeb 16 '24Sale10.243,32134,006264,679Feb 16 06:56 PM
Last Close
Jan 30 10:08AM ET
23.96
Dollar change
+0.55
Percentage change
2.35
%
DNLI Denali Therapeutics Inc daily Stock Chart
IndexRUT P/E- EPS (ttm)-2.76 Insider Own13.43% Shs Outstand143.84M Perf Week2.92%
Market Cap3.45B Forward P/E- EPS next Y-3.02 Insider Trans-1.36% Shs Float124.59M Perf Month16.25%
Income-427.49M PEG- EPS next Q-0.82 Inst Own88.55% Short Float6.40% Perf Quarter-13.75%
Sales0.00M P/S- EPS this Y-162.11% Inst Trans6.37% Short Ratio8.47 Perf Half Y-1.03%
Book/sh9.17 P/B2.61 EPS next Y-8.83% ROA-31.77% Short Interest7.97M Perf Year36.76%
Cash/sh5.81 P/C4.12 EPS next 5Y- ROE-35.09% 52W Range14.56 - 33.33 Perf YTD17.57%
Dividend Est.- P/FCF- EPS past 5Y-21.99% ROI-31.36% 52W High-28.11% Beta1.43
Dividend TTM- Quick Ratio9.98 Sales past 5Y350.08% Gross Margin- 52W Low64.56% ATR (14)1.19
Dividend Ex-Date- Current Ratio9.98 EPS Y/Y TTM-197.15% Oper. Margin- RSI (14)59.20 Volatility4.68% 6.04%
Employees445 Debt/Eq0.04 Sales Y/Y TTM-100.00% Profit Margin- Recom1.18 Target Price40.00
Option/ShortYes / Yes LT Debt/Eq0.03 EPS Q/Q12.36% Payout- Rel Volume0.42 Prev Close23.41
Sales Surprise-100.00% EPS Surprise-5.86% Sales Q/Q-100.00% EarningsNov 06 AMC Avg Volume940.63K Price23.96
SMA2010.63% SMA505.52% SMA2002.94% Trades Volume56,403 Change2.35%
Date Action Analyst Rating Change Price Target Change
Jan-07-25Initiated Robert W. Baird Outperform $31
Jan-03-25Initiated William Blair Outperform
Dec-16-24Upgrade Stifel Hold → Buy $37
Oct-10-24Resumed Raymond James Mkt Perform
Oct-07-24Downgrade Cantor Fitzgerald Overweight → Neutral
Dec-13-23Initiated Citigroup Buy $32
Nov-20-23Resumed JP Morgan Overweight $28
Oct-24-23Resumed Cantor Fitzgerald Overweight $85 → $35
Sep-06-23Initiated B. Riley Securities Buy $38
Jan-30-23Initiated SVB Securities Outperform $50
Today 08:00AM
Jan-17-25 11:18AM
Jan-13-25 08:00AM
Jan-08-25 08:00AM
07:25AM
04:33PM Loading…
Jan-07-25 04:33PM
04:08PM
02:16PM
12:48PM
10:13AM
10:13AM
09:33AM
04:41AM
Jan-06-25 04:30PM
Jan-03-25 01:08PM
06:25AM Loading…
Dec-17-24 06:25AM
Dec-06-24 11:31AM
Dec-05-24 08:00AM
Nov-06-24 04:01PM
Oct-29-24 10:01AM
Oct-13-24 04:56PM
Sep-16-24 11:22AM
Sep-04-24 08:15AM
Sep-03-24 08:00AM
Aug-19-24 10:13AM
Aug-14-24 02:00PM
Aug-06-24 09:55AM
Aug-01-24 06:45AM
Jul-23-24 06:13AM
Jul-16-24 03:19PM
07:09PM Loading…
Jul-08-24 07:09PM
Jun-28-24 08:37AM
Jun-24-24 09:07AM
Jun-12-24 07:00AM
Jun-06-24 11:31AM
Jun-04-24 01:17PM
Jun-03-24 08:00AM
May-09-24 07:00AM
May-08-24 11:17AM
09:16AM
08:20AM
May-07-24 10:56PM
05:56PM
04:01PM
May-01-24 08:00AM
Apr-09-24 08:46AM
Apr-08-24 08:00AM
Mar-28-24 11:30AM
Mar-19-24 08:30AM
Feb-28-24 08:08AM
Feb-27-24 08:31AM
08:05AM
08:00AM
06:53AM
Feb-16-24 08:39AM
08:22AM
07:13AM
Feb-07-24 08:00AM
Feb-01-24 08:00AM
Jan-31-24 11:04PM
Jan-26-24 10:00AM
Jan-11-24 01:11PM
Jan-09-24 08:44AM
Jan-08-24 08:00AM
06:30AM
06:30AM
Jan-02-24 01:57PM
Dec-22-23 06:22AM
Dec-21-23 09:55AM
Dec-07-23 11:31AM
Nov-27-23 07:01PM
09:55AM
Nov-21-23 06:00AM
Nov-07-23 05:50PM
04:01PM
Nov-06-23 09:55AM
Nov-01-23 10:30AM
Oct-19-23 10:30AM
Oct-06-23 04:41AM
Oct-02-23 07:00AM
Sep-27-23 08:31AM
Sep-11-23 06:30AM
Sep-09-23 03:59PM
Sep-07-23 11:30AM
Aug-30-23 08:30AM
Aug-29-23 09:00AM
Aug-11-23 11:36AM
Aug-10-23 12:02PM
06:03AM
Aug-08-23 06:05PM
04:01PM
Jun-29-23 05:13AM
Jun-27-23 02:23PM
Jun-26-23 10:00AM
Jun-21-23 03:21PM
06:00AM
Jun-20-23 04:20PM
07:00AM
Jun-09-23 11:30AM
Jun-08-23 11:30AM
Denali Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates for neurodegenerative diseases. Its product pipeline includes LRRK2, RIPK1, TREM2, and Tau. The company was founded by Ryan J. Watts, Marc Tessier-Lavigne, and Alexander Schuth on October 14, 2013 and is headquartered in San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ho CaroleChief Medical OfficerJan 06 '25Sale20.2212,255247,796178,580Jan 08 08:26 PM
Ho CaroleChief Medical OfficerJan 07 '25Sale20.812,90760,495175,673Jan 08 08:26 PM
Schuth Alexander O.COFO and SecretaryJan 06 '25Sale20.2212,255247,796247,215Jan 08 08:25 PM
Schuth Alexander O.COFO and SecretaryJan 07 '25Sale20.812,90760,495244,308Jan 08 08:25 PM
Watts Ryan J.President and CEOJan 06 '25Sale20.2229,266591,759260,721Jan 08 08:24 PM
Watts Ryan J.President and CEOJan 07 '25Sale20.817,650159,196253,071Jan 08 08:24 PM
Krognes Steve E.DirectorJan 07 '25Sale20.813,33969,48525,757Jan 08 08:23 PM
Ho CaroleOfficerJan 07 '25Proposed Sale20.812,90760,495Jan 07 08:14 PM
Schuth Alexander O.OfficerJan 07 '25Proposed Sale20.812,90760,495Jan 07 08:12 PM
Watts Ryan J.DirectorJan 07 '25Proposed Sale20.817,650159,196Jan 07 08:10 PM
Krognes Steve E.DirectorJan 07 '25Proposed Sale20.813,33969,485Jan 07 08:08 PM
Schuth Alexander O.OfficerJan 06 '25Proposed Sale20.2212,255247,781Jan 07 08:06 PM
Watts Ryan J.DirectorJan 06 '25Proposed Sale20.2229,266591,723Jan 07 08:03 PM
Ho CaroleOfficerJan 06 '25Proposed Sale20.2212,255247,786Jan 07 08:01 PM
SATO VICKI LDirectorJan 02 '25Sale20.913,08064,403107,976Jan 03 04:13 PM
VICKI LEE SATODirectorJan 02 '25Proposed Sale20.386,160125,541Jan 02 04:23 PM
Schuth Alexander O.COFO and SecretaryDec 27 '24Option Exercise5.286,70835,418205,290Dec 31 04:18 PM
STEVE KROGNESDirectorDec 31 '24Proposed Sale20.2430,000607,200Dec 31 04:17 PM
Ho CaroleChief Medical OfficerNov 25 '24Option Exercise0.6817,84512,135136,655Nov 27 04:44 PM
Schuth Alexander O.COFO and SecretaryNov 22 '24Option Exercise0.6820,51613,951198,582Nov 26 05:19 PM
Schenkein David PDirectorNov 11 '24Option Exercise18.0047,165848,97068,661Nov 13 04:18 PM
Schenkein David PDirectorNov 11 '24Sale32.5159,4411,932,6659,220Nov 13 04:18 PM
Schuth Alexander O.COFO and SecretaryNov 07 '24Option Exercise5.2815,55882,146193,624Nov 12 04:44 PM
Schuth Alexander O.COFO and SecretaryNov 07 '24Sale29.9115,558465,286178,066Nov 12 04:44 PM
SATO VICKI LDirectorNov 07 '24Sale30.001,02030,600111,056Nov 12 04:43 PM
DAVID SCHENKEINDirectorNov 11 '24Proposed Sale31.3559,4411,863,475Nov 12 07:47 AM
ALEXANDER SCHUTHOfficerNov 07 '24Proposed Sale29.5515,558459,739Nov 07 04:39 PM
SATO VICKI LDirectorNov 01 '24Sale27.073,08083,376112,076Nov 05 04:21 PM
Watts Ryan J.President and CEOOct 18 '24Option Exercise0.6840,00027,200275,807Oct 22 04:30 PM
Watts Ryan J.President and CEOOct 18 '24Sale27.6940,0001,107,600235,807Oct 22 04:30 PM
RYAN WATTSDirectorOct 18 '24Proposed Sale27.4240,0001,096,800Oct 18 04:19 PM
Krognes Steve E.DirectorSep 30 '24Sale29.0330,000870,90029,096Oct 02 04:37 PM
STEVE KROGNESDirectorSep 30 '24Proposed Sale29.4330,000882,900Sep 30 04:25 PM
SATO VICKI LDirectorSep 13 '24Sale30.001,02030,600115,156Sep 16 04:17 PM
VICKI LEE SATODirectorSep 13 '24Proposed Sale27.966,160172,234Sep 13 04:25 PM
SATO VICKI LDirectorSep 03 '24Sale25.003,08077,007116,176Sep 04 06:26 PM
Watts Ryan J.President and CEOAug 20 '24Sale23.792,26053,765235,807Aug 22 04:16 PM
Krognes Steve E.DirectorAug 20 '24Sale23.791,72741,08532,677Aug 22 04:15 PM
Schuth Alexander O.COFO and SecretaryAug 20 '24Sale23.655,806137,286180,613Aug 22 04:14 PM
Schuth Alexander O.COFO and SecretaryAug 21 '24Sale24.782,54763,115178,066Aug 22 04:14 PM
Ho CaroleChief Medical OfficerAug 21 '24Sale24.5720,005491,571118,810Aug 22 04:14 PM
Ho CaroleChief Medical OfficerAug 20 '24Sale23.792,45358,357138,815Aug 22 04:14 PM
CAROLE HOOfficerAug 21 '24Proposed Sale23.6520,005473,118Aug 21 04:42 PM
ALEXANDER SCHUTHOfficerAug 21 '24Proposed Sale23.652,54760,237Aug 21 04:40 PM
Krognes Steve E.DirectorAug 20 '24Proposed Sale23.791,72741,085Aug 20 08:09 PM
Schuth Alexander O.OfficerAug 20 '24Proposed Sale23.792,45358,357Aug 20 08:09 PM
Watts Ryan J.DirectorAug 20 '24Proposed Sale23.792,26053,765Aug 20 08:08 PM
Ho CaroleOfficerAug 20 '24Proposed Sale23.792,45358,356Aug 20 08:08 PM
ALEXANDER SCHUTHOfficerAug 20 '24Proposed Sale23.953,35380,304Aug 20 04:27 PM
Schuth Alexander O.COFO and SecretaryAug 13 '24Sale22.892,27252,006186,419Aug 15 04:10 PM
Ho CaroleChief Medical OfficerAug 13 '24Sale22.892,33753,494141,268Aug 15 04:09 PM
Schuth Alexander O.OfficerAug 13 '24Proposed Sale22.892,27252,006Aug 13 08:37 PM
Ho CaroleOfficerAug 13 '24Proposed Sale22.892,33753,494Aug 13 08:36 PM
Krognes Steve E.DirectorJul 01 '24Sale22.1230,000663,66834,404Jul 03 09:13 PM
Krognes Steve E.DirectorJun 13 '24Sale21.7968814,99252,620Jul 03 09:13 PM
SATO VICKI LDirectorJul 01 '24Sale22.143,08068,204119,256Jul 03 09:13 PM
Cook Jennifer E.DirectorJun 06 '24Sale21.731,45831,68220,038Jun 10 08:06 PM
SATO VICKI LDirectorMay 15 '24Sale20.391,67434,133116,369May 17 04:28 PM
SATO VICKI LDirectorApr 15 '24Sale18.291,66630,471118,043Apr 17 05:14 PM
Krognes Steve E.DirectorApr 01 '24Sale20.5092,5001,896,25047,341Apr 02 06:07 PM
SATO VICKI LDirectorMar 15 '24Sale20.101,66633,487119,709Mar 19 04:27 PM
SATO VICKI LDirectorFeb 15 '24Sale18.371,66630,604121,375Feb 20 05:38 PM
Krognes Steve E.DirectorFeb 13 '24Sale17.292,75047,548139,841Feb 15 09:16 PM
Watts Ryan J.President and CEOFeb 13 '24Sale17.299,589165,794238,067Feb 15 09:15 PM
Ho CaroleChief Medical OfficerFeb 13 '24Sale17.292,78448,135145,010Feb 15 09:14 PM
Ho CaroleChief Medical OfficerFeb 14 '24Sale17.791,40524,995143,605Feb 15 09:14 PM
Schuth Alexander O.COFO and SecretaryFeb 14 '24Sale17.6620,128355,460187,341Feb 15 09:14 PM
Schuth Alexander O.COFO and SecretaryFeb 13 '24Sale17.292,71646,960207,469Feb 15 09:14 PM
Schuth Alexander O.COFO and SecretaryFeb 08 '24Option Exercise0.6850,00034,000210,185Feb 12 04:48 PM